Skip to main navigation
Skip to content
Customer Service: 866-788-9007
PHYSICIAN LOGIN
|
CRF LOGIN
ORDER TEST
Main Menu
Company
Menu Toggle
About Us
History
Executive Management
Board of Directors
Licenses
Careers
Contact Us
Products
Menu Toggle
Cutaneous Melanoma
DecisionDx-Melanoma
DecisionDx-CM
Seq
Uveal Melanoma
DecisionDx-UM
DecisionDx-UM
Seq
DecisionDx-PRAME
Research & Development
Menu Toggle
Our Approach
Tests in Development
Cutaneous Squamous Cell Carcinoma
Suspicious Pigmented Lesions
Investors
Menu Toggle
Overview
Menu Toggle
News & Events
Menu Toggle
Press Releases
Menu Toggle
Events & Presentations
Menu Toggle
Stock Information
Menu Toggle
Stock Quote & Chart
Menu Toggle
Historic Price Lookup
Menu Toggle
Investment Calculator
Menu Toggle
Financials & Filings
Menu Toggle
SEC Filings
Menu Toggle
Analyst Coverage
Menu Toggle
Corporate Governance
Menu Toggle
Documents & Charters
Menu Toggle
Board of Directors
Menu Toggle
Management
Menu Toggle
Committee Composition
Menu Toggle
Investor Resources
Menu Toggle
Annual Meeting
Menu Toggle
Investor FAQs
Menu Toggle
Investor Contact
Menu Toggle
Email Alerts
Menu Toggle
Scientific Publications
Resources
Menu Toggle
Healthcare Professionals
Login/Register
Order a Test
Reimbursement
Patients
Overview of our Tests
Frequently Asked Questions
Insurance Coverage
July 2, 2020
Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
Events & Presentations
Events & Presentations
Castle Biosciences Q3 2019 Earnings Call
Nov 11, 2019 at 4:30 PM EST
Site - Investor Tools
Print Page
Print Page
RSS Feeds
RSS Feeds
Email Alerts
Email Alerts
Investor Contact
Investor Contact
Search
Search
7ads6x98y
